Biotech Stocks Tumble But Fundamentals Strong, Analysts Say
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech sell-off March 21 and March 24 left many in the industry wondering if the biotech bull market, more than two years running, might finally be fading. Key catalysts could reinvigorate the sector, however.